Shon SooBum, Kim Hyangkyoung, Kim Hyeong Cheol, Cho Sungsin, Lee Seung Hwan, Joh Jin Hyun
Department of Surgery, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
Ann Surg Treat Res. 2023 Jan;104(1):27-33. doi: 10.4174/astr.2023.104.1.27. Epub 2023 Jan 2.
Limited data are available on the nationwide trend of treatments for chronic venous disease (CVD). The aim of the present study was to identify the nationwide trends of CVD treatments in Korea.
A serial, cross-sectional study was conducted with the use of time trends to analyze patients with CVD between 2010 and 2020. The trends in the number of patients and procedures were analyzed including sclerotherapy, open surgery, and endovenous thermal ablation (ETA). Health Insurance Review and Assessment Service data were used to analyze the trends. For the statistical analysis, MedCalc Statistical software was used. P < 0.05 was considered statistically significant.
A total of 1,867,307 patients with CVD were managed in Korea between 2010 and 2020. The annual number of patients with CVD increased from 143,108 in 2010 to 219,319 in 2020 (risk ratio [RR], 1.53; P < 0.001). The percentage of patients with CVD who had venous ulcer gradually decreased from 3.1% in 2010 to 1.7% in 2020 (RR, 0.86; P < 0.001). The number of conventional surgeries including stripping and local resection of varicose veins decreased from 32,384 in 2010 to 21,792 in 2020 (RR, 0.67; P < 0.001). The number of ETAs performed increased, from 290 in 2011 to 12,126 procedures in 2020 (RR, 41.81; P < 0.001).
The total number of patients with CVD increased during the last 11 years. The number of conventional open surgery and sclerotherapy procedures decreased. On the contrary, the number of ETAs significantly increased in Korea.
关于慢性静脉疾病（CVD）治疗的全国性趋势的数据有限。本研究的目的是确定韩国CVD治疗的全国性趋势。
采用时间趋势进行系列横断面研究，以分析2010年至2020年期间的CVD患者。分析了患者数量和手术数量的趋势，包括硬化疗法、开放手术和腔内热消融（ETA）。使用健康保险审查和评估服务数据来分析趋势。进行统计分析时使用了MedCalc统计软件。P < 0.05被认为具有统计学意义。
2010年至2020年期间，韩国共管理了1,867,307例CVD患者。CVD患者的年度数量从2010年的143,108例增加到2020年的219,319例（风险比[RR]，1.53；P < 0.001）。患有静脉溃疡的CVD患者百分比从2010年的3.1%逐渐下降到2020年的1.7%（RR，0.86；P < 0.001）。包括静脉曲张剥脱术和局部切除术在内的传统手术数量从2010年的32,384例减少到2020年的21,792例（RR，0.67；P < 0.001）。ETA的实施数量增加，从2011年的290例增加到2020年的12,126例（RR，41.81；P < 0.001）。
在过去11年中，CVD患者的总数有所增加。传统开放手术和硬化疗法的数量减少。相反，韩国的ETA数量显著增加。
